...
首页> 外文期刊>Critical care : >Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
【24h】

Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?

机译:在肾脏替代治疗期间测量急性肾脏损伤的生物标志物:智慧还是愚蠢?

获取原文
           

摘要

Early data are now appearing relating to the measurement of biomarkers of acute kidney injury during renal replacement therapy. These data go some way in describing the clearance of these molecules during renal support. Understanding the potential clearance, or otherwise, of these proteins may lead to directing our therapies in the future particularly with regard to cessation of renal support. We describe a recent study which has provided data that may aid in addressing this issue.
机译:现在出现的早期数据与在肾脏替代治疗期间急性肾损伤的生物标志物的测量有关。这些数据以某种方式描述了肾脏支持期间这些分子的清除情况。了解这些蛋白质的潜在清除或其他方式可能导致将来指导我们的治疗,尤其是在停止肾脏支持方面。我们描述了一项最近的研究,该研究提供了有助于解决此问题的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号